BIOO Scientific Corp. Receives Two Grants from US Agencies
News Jan 04, 2008
BIOO Scientific Corp. has announced that it was awarded $285,000 from the National Institute of Allergy and Infectious Disease to fund research titled "Engineered Polypeptides for Improved Antibody Production". This grant will utilize BIOO’s expertise in antibody and protein manufacturing to produce antibodies that are more specific than traditional antibodies.
The U.S. National Science Foundation research project for $100,000 titled "Improved in Vivo Delivery of SiRNA".
In addition to this, BIOO Scientific has launched a series on new products surrounding the use of siRNA and miRNA in vivo and will be the sponsor of the Feodor Lynen Lecturer, Susan Gottesman from NIH, speaking on Sunday morning, February 3, 2008 at the Miami Winter Symposium.
CRISPR Causes More Genome Damage Than First ThoughtNews
Researchers have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.